发明名称 |
Use of TGF-beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia |
摘要 |
The disclosure relates to methods of treating an infant at risk of developing bronchopulmonary dysplasia, including premature infants, by administering a TGF-beta antagonist during the perinatal period, including the prenatal period and/or the postnatal period. For administration during the prenatal period, the TGF-beta antagonist can be administered either directly to the infant in utero, or indirectly by administration to the mother. |
申请公布号 |
US8642034(B2) |
申请公布日期 |
2014.02.04 |
申请号 |
US20070444059 |
申请日期 |
2007.10.03 |
申请人 |
STREISAND JAMES B.;ROBERTS, JR. JESSE D.;GENZYME CORPORATION |
发明人 |
STREISAND JAMES B.;ROBERTS, JR. JESSE D. |
分类号 |
A61K39/395;A61K38/17;C07K14/495;C07K14/71;C07K14/785;C07K16/22;C07K16/28 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|